Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer’s Association and the Society for Nuclear Medicine and Molecular Imaging and published online Jan. 8 in both Alzheimer’s & Dementia and the Journal of Nuclear Medicine.